It is believed that dengue virus (DENV) is transfusion transmittable, only a few transfusion associated cases were reported so far in spite of at least 50 million dengue infections occur globally each year. The equation for calculating DENV transfusion transmission probability was proposed following the West Nile Virus model. In consideration of reported case number, population size in the region around the designated cases, symptomatic infection rate, blood donation rate, and mosquito biological characteristics together, a relative low rate of DENV transmittable donations was presumed in a low-grade endemic area. Both the apparent clinical presentation and the relative short viremia period of DENV infection prevent dengue viruses from being a highly potential transfusion transmittable agent. The geographically based selection and donor deferral strategy seems to effectively mitigate the potential risk of DENV transfusion transmission. The costly minipooled nucleic acid test (NAT) is therefore not recommended unless for ensuring enough safe blood donations in the dengue epidemic area.